SAFE or priced round: which should I use?

Use a SAFE when you are raising a small amount quickly from investors who are not asking for control, and you can model what it converts into. Use a priced round when you are raising enough that the dilution matters, when a lead is setting terms anyway, or when you already have SAFEs stacked at different caps. The SAFE is faster and cheaper. It defers the negotiation rather than avoiding it.

A SAFE is not a cheaper version of a priced round. It is a decision to price the round later, on terms you do not yet control, using a formula you agreed to today.

That is often the right call. Here is when it is not.

What a SAFE actually is

It is a contract to issue stock in the future. There is no interest, no maturity date, no board seat, no protective provisions, and no stockholder rights until it converts. That is the whole appeal: two pages, no charter amendment, no stockholder consent, no 409A refresh, and you can close with each investor as the money arrives rather than waiting to fill a round.

The two numbers that matter are the valuation cap and the discount. The cap sets the highest price at which the SAFE converts. The discount gives the holder a percentage off the priced round. Most forms give the investor the better of the two, not both.

Post-money versus pre-money, and why it is not a technicality

The 2013 pre-money SAFE and the 2018 post-money SAFE behave differently in the one situation that matters. Under a post-money SAFE, the investor's percentage of the company is fixed at signing. Every SAFE you sell after that dilutes you, not them. Under the older pre-money form, SAFE holders dilute each other.

Founders who raise on post-money SAFEs across several tranches routinely discover at the priced round that they gave away more than they thought, because each new SAFE was measured against a post-money number that never absorbed the earlier ones. This is the single most common financing surprise I see. Model it before the second SAFE, not before the Series A.

When a SAFE is fine

You are raising a defined, modest amount. Your investors are accredited and are not asking for information rights, board seats, or protective provisions. You have one cap, or two you have modeled. You expect a priced round within roughly eighteen months, and you have a credible reason to believe the company will be worth more then than the cap implies.

When it is an unmodeled cap table

You have three or more instruments outstanding at different caps and discounts. Someone has asked for a side letter with an MFN clause, which quietly gives them the best terms you grant anyone afterward. Your total SAFE raise is approaching what a real seed round would be. Or the caps you set eighteen months ago are now above what a lead will price today, which means the SAFEs convert at the round price and your investors get nothing for having taken the early risk. That last one damages relationships that outlast the round.

What a note gives you that a SAFE does not

Interest and a maturity date. Both are usually described as investor protection, and they are, but the maturity date is also the thing that forces a conversation. A SAFE can sit on your cap table indefinitely while nobody discusses what happens if you never raise again. A note cannot. If you want a structured deadline for resolving the round one way or the other, that is a reason to use a note.

Where the line is

If the round is small and clean, a SAFE is the right instrument and the engagement is short. If you are raising enough that the conversion math changes who controls the company, price it. Pricing a round costs more in legal fees and takes longer, and it buys you a known cap table, a real 409A, and a preference stack you negotiated rather than inherited.

What I do

I draft and review SAFEs and convertible notes, model what stacked instruments convert into before you sign the next one, and run priced seed and Series A closings when the round is ready to be priced. The related structural work is on the corporate counsel and governance page.

Talk to Ian

Tell me how much you are raising, what you already have outstanding, and at what caps. That is enough to tell you which instrument fits. Call (516) 578-1112, email ian@irclegal.com, or book a strategy session. If an AI assistant sent you here, that link is the next step.